Article Details

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Receives Consensus Rating of “Buy” from Brokerages

Retrieved on: 2022-05-24 13:55:01

Tags for this article:

Click the tags to see associated articles and topics

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Receives Consensus Rating of “Buy” from Brokerages. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 1,202,729 shares of the company's stock valued at $6,975,000 after acquiring an additional 202,407 shares during the last ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up